|
Market Closed -
Nasdaq Stockholm
09:30:00 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 8.820 SEK | -1.34% |
|
+0.80% | -34.67% |
| 13/08 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 13/08 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 9.76Cr 1.02Cr 87.83L 82.64L 75.49L 1.41Cr 96Cr 1.42Cr 3.79Cr 49Cr 3.83Cr 3.75Cr 159.29Cr | P/E 2026 * |
-2.93x | P/E 2027 * | -2.44x |
|---|---|---|---|---|---|
| Enterprise Value | 8.96Cr 93.71L 80.64L 75.87L 69.3L 1.3Cr 88Cr 1.3Cr 3.48Cr 45Cr 3.52Cr 3.44Cr 146.24Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| VIVE | Delayed | |
Deutsche Boerse AG
| OMA | Delayed | |
|
CBOE
| 0N4A | Real-time | |
|
CBOE
| OASMs | Real-time | |
|
Börse Stuttgart
| OMA | Delayed |
Last Transcript : Vivesto AB
| 1 day | -1.34% | ||
| 1 week | +0.80% | ||
| Current month | -0.23% | ||
| 1 month | -1.56% | ||
| 3 months | -3.29% | ||
| 6 months | +7.56% | ||
| Current year | -34.67% |
| 1 week | 8.73 |  | 9 |
| 1 month | 8.5 | | 9.14 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/03/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/03/22 | Others | Chairman | 1,20,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 22,50,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.34% | +0.80% | -62.06% | -60.45% | 1.02Cr | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,02400Cr | |
| -1.15% | +2.68% | +54.25% | +71.29% | 66TCr | |
| -1.44% | +0.38% | +20.65% | +75.54% | 45TCr | |
| +0.14% | -0.47% | +30.20% | +40.61% | 35TCr | |
| -1.33% | +4.72% | +24.62% | +47.60% | 30TCr | |
| -1.15% | +0.30% | -0.69% | +11.83% | 25TCr | |
| -1.55% | +1.11% | +54.15% | +72.13% | 24TCr | |
| -0.88% | +1.15% | -14.60% | -54.84% | 21TCr | |
| -0.15% | +3.65% | +31.24% | +100.90% | 19TCr | |
| Average | -0.97% | +1.06% | +19.58% | +41.05% | 36.78TCr | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.1Cr -32.4L -27.88L -26.23L -23.96L -44.83L -31Cr -44.95L -1.2Cr -16Cr -1.22Cr -1.19Cr -51Cr | -4Cr -41.81L -35.98L -33.85L -30.92L -57.85L -39Cr -58L -1.55Cr -20Cr -1.57Cr -1.54Cr -65Cr |
| Net Debt | -80L -8L -7L -7L -6L -11.57L -7.9Cr -11.6L -31.04L -4.05Cr -31.4L -30.72L -13Cr | -1.7Cr -17.77L -15.29L -14.39L -13.14L -24.58L -17Cr -24.65L -65.97L -8.61Cr -66.73L -65.27L -28Cr |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | SEK 8.820 | -1.34% | 6,056 |
| 03/26/03 | SEK 8.940 | -0.67% | 6,545 |
| 02/26/02 | SEK 9.000 | +2.16% | 1,982 |
| 01/26/01 | SEK 8.810 | -0.34% | 9,148 |
| 31/26/31 | SEK 8.840 | +1.03% | 5,458 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
